Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

U.S. patent for antithrombotic agents issued to Burnham Institute

Sep. 10, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

RPR discloses new factor Xa inhibitors

Sep. 10, 1997

Promising phase II results for Genzyme Transgenics' rhATIII

Sep. 9, 1997

Novastan granted priority review status by FDA

Sep. 9, 1997

T-686 inhibits thrombus formation without hemostatic impairment

Sep. 5, 1997

RPR scientists try a new approach to gpIIb/IIIa antagonists

Sep. 5, 1997

DuPont Merck discloses new anticoagulants

Sep. 4, 1997

Reteplase is superior to alteplase in pulmonary embolism

Sep. 2, 1997

New inhibitors of platelet aggregation from Taiwan

Sep. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 25, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...